Bone cancer: Is the osteosarcoma genome targetable?

Affiliations

¹ Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, Maryland 20892, USA.

Comment

Sharon A Savage et al. Nat Rev Endocrinol. 2017 Sep.

. 2017 Sep;13(9):506-508.

doi: 10.1038/nrendo.2017.101. Epub 2017 Aug 4.

¹ Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, Maryland 20892, USA.

No abstract available

Comment on

Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.
Behjati S, Tarpey PS, Haase K, Ye H, Young MD, Alexandrov LB, Farndon SJ, Collord G, Wedge DC, Martincorena I, Cooke SL, Davies H, Mifsud W, Lidgren M, Martin S, Latimer C, Maddison M, Butler AP, Teague JW, Pillay N, Shlien A, McDermott U, Futreal PA, Baumhoer D, Zaikova O, Bjerkehagen B, Myklebost O, Amary MF, Tirabosco R, Van Loo P, Stratton MR, Flanagan AM, Campbell PJ. Behjati S, et al. Nat Commun. 2017 Jun 23;8:15936. doi: 10.1038/ncomms15936. Nat Commun. 2017. PMID: 28643781 Free PMC article.